CRBP · Corbus Pharmaceuticals Holdings, Inc. · Executive Compensation
$2.06
-0.38 (-15.40%)
At close · Nov 20
Return incl. dividend (before tax)
Q4 2020 earnings call transcript
Market Cap
$42.45M
Shares
20.61M
Volume · Nov 20
1.38M
Avg daily vol (3M)
1.1M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $3,750,125 |
| Dominic Smethurst | Chief Medical Officer | $1,800,142 |
| Sean Moran | Chief Financial Officer | $1,789,423 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $4,245,438 |
| Dominic Smethurst | Chief Medical Officer | $2,892,972 |
| Sean Moran | Chief Financial Officer | $2,429,505 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $1,137,622 |
| Rachael Brake | Chief Scientific Officer | $839,867 |
| Sean Moran | Chief Financial Officer | $717,256 |
| Dominic Smethurst | Chief Medical Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $1,442,841 |
| Sean Moran | Chief Financial Officer | $778,616 |
| Rachael Brake | Chief Scientific Officer | $763,795 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $4,858,306 |
| Sean Moran | Chief Financial Officer | $1,844,917 |
| Rachael Brake | Chief Scientific Officer | $15,807 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nishant Saxena | Chief Business Officer | Appointed | 2026-05-21 |
| Nishant Saxena | Chief Business Officer | Appointed | 2026-05-21 |
| Brent Pfeiffenberger | member of the Board | Appointed | 2026-05-14 |
| Dominic Smethurst | Chief Medical Officer | Resigned | 2026-04-07 |
|
Alan Holmer
“Mr. Holmer’s decision to resign was not the result of any disagreement with the Company or its management on any matter relating to the Company’s operations, policies or practices.”
|
Board of Directors | Retired | 2025-12-18 |
| Ian Hodgson | Chief Operating Officer | Appointed | 2025-03-18 |
|
Avery W. Catlin
“Mr. Catlin’s resignation was not the result of any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.”
|
member of the Board’s Audit Committee and Compensation Committee | Resigned | 2024-08-20 |
| Winston W. Kung | member of the Board | Appointed | 2024-08-20 |
|
Avery W. Catlin
“Mr. Catlin’s resignation was not the result of any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.”
|
member of the Board of Directors | Resigned | 2024-08-20 |
| Yong Ben | director | Appointed | 2024-05-20 |
| Anne Altmeyer | director |
Already on the board
Since at least 2022: re-election or new board role
|
2024-05-20 |
| John Jenkins | director |
Already on the board
Since at least 2018: re-election or new board role
|
2024-05-20 |
| Peter Salzmann | director |
Already on the board
Since at least 2020: re-election or new board role
|
2024-05-20 |
| Rachelle Jacques | director |
Already on the board
Since at least 2019: re-election or new board role
|
2024-05-20 |
| Avery W. Catlin | director | Appointed | 2024-05-20 |
| Alan Holmer | director | Appointed | 2024-05-20 |
| Yuval Cohen | director |
Already on the board
Since at least 2014: re-election or new board role
|
2024-05-20 |
| Rachael Brake, Ph.D. | Chief Scientific Officer | Resigned | 2024-02-06 |
| Yong Ben | Board of Directors | Appointed | 2023-03-07 |
| Craig Millian | Chief Operating Officer | Resigned | 2023-03-07 |
| Yong Ben, M.D., MBA | member of the Board | Appointed | 2023-03-06 |
| Anne Altmeyer, Ph.D., MBA, MPH | member of the Board | Appointed | 2022-09-26 |
| Craig Millian | Chief Operating Officer | Appointed | 2021-09-28 |
| Barbara White | Chief Medical Officer and Head of Research | Resigned | 2021-08-18 |
Leadership
- Yuval Cohen CEO, Board Member
- Alan Holmer Chairman, Board Member
- Sean Moran CFO
- Craig Millian COO
- Ian Hodgson COO
- Anne Altmeyer Board Member
- Anne Altmeyer, Ph.D., MBA, MPH Board Member
- Avery W. Catlin Board Member
- Brent Pfeiffenberger Board Member
- George S. Golumbeski Board Member
- John Jenkins Board Member
- Rachelle Jacques Board Member
- Winston Kung Board Member
- Winston W. Kung Board Member
- Yong Ben Board Member
- Yong Ben, M.D., MBA Board Member
Key facts
CIK
1595097
CUSIP
21833P301
13F (30d)
129 filings
111 filers
Visit website
Investor relations